Telix and Ekalia to produce astatine-211 near Philadelphia

Go back to Telix and Ekalia to produce astatine-211 near Philadelphia

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

October 19, 2026 1:30 AM EDT

Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy (TAT).Secures long-term, priority isotope access for Telix's alpha therapy pipeline, including its TLX102-Tx candidate for glioblastoma and leptomeningeal disease, while also supporting third-party academic and industry programs.First IBA alpha-beam cyclotron to be installed and operated at Telix's RLS Radiopharmacies site near Philadelphia, PA.Leverages Telix's vertically integrated U.S.... More